Skip to main content

Ketosis vs Ketoacidosis: The Difference

Nutritional ketosis and diabetic ketoacidosis (DKA) both involve ketones, but only DKA includes metabolic acidosis. A ketone reading by itself cannot diagnose either condition or establish that someone is safe.

Seek emergency care now for persistent vomiting, severe abdominal pain, deep or difficult breathing, confusion, fainting, or marked drowsiness. These signs are especially concerning for DKA with known or possible diabetes, pregnancy, or SGLT2-inhibitor use; do not wait for very high glucose. A normal or mildly elevated glucose reading does not rule out DKA.1 2

How clinicians distinguish ketosis from DKA

The 2024 international consensus defines DKA using three required components. A person must have diabetes or qualifying hyperglycemia, elevated ketones, and metabolic acidosis.1

Clinical questionNutritional ketosisDiabetic ketoacidosis
Why are ketones present?Carbohydrate or energy availability is low enough to increase ketone productionInsulin action is insufficient and counter-regulatory hormones drive excessive ketone production
Ketone resultVariable; no single reading proves safety or benefitBlood beta-hydroxybutyrate (BHB) at least 3.0 mmol/L, or urine ketones at least 2+, satisfies the ketone component
Glucose or diabetes componentNo DKA requirementGlucose at least 200 mg/dL (11.1 mmol/L), or a prior history of diabetes regardless of the current glucose
Acid-base statusNo metabolic acidosisVenous pH below 7.3 and/or bicarbonate below 18 mmol/L
What the result meansA metabolic response, not a medical goal by itselfA life-threatening emergency requiring clinical treatment

All three DKA components matter. Blood BHB can reach the DKA criterion before glucose becomes markedly high, while ketones from fasting or diet do not by themselves establish acidosis. Home meters cannot measure pH or bicarbonate, so they cannot confirm or exclude DKA.1

What happens during nutritional ketosis?

When carbohydrate or total energy availability falls, the liver converts fatty-acid-derived acetyl-CoA into ketone bodies. BHB and acetoacetate can then supply part of the energy used by the brain and other tissues. Insulin remains present and normally restrains ketone production, while blood pH and bicarbonate remain within their usual ranges.4

Nutritional ketosis is not defined by a universally beneficial target band. Ketone concentration varies with recent food intake, fasting, exercise, illness, pregnancy, alcohol use, medications, and the method and timing of measurement. Most people following a ketogenic diet for general purposes do not need routine ketone testing.

The site's science of ketosis guide explains the pathway in more detail. The blood ketone meter and urine strip entries explain what home tests can and cannot show.

What happens during DKA?

In DKA, absolute or relative insulin deficiency combines with increased counter-regulatory hormones. Glucose production and ketone production rise, fluid and electrolytes are lost, and ketone acids lower bicarbonate and pH. Infection, missed or inadequate insulin, a new presentation of diabetes, and acute cardiovascular illness are common precipitating factors.1

Blood BHB is the preferred ketone measurement because it is the principal ketoacid in DKA. Urine tests detect acetoacetate instead. They can underestimate ketonemia early in DKA and overestimate it during recovery as BHB is converted back to acetoacetate. The consensus therefore recommends direct blood BHB for diagnosis and monitoring when available.1

Euglycemic DKA and SGLT2 inhibitors

About 10% of adults with DKA in the consensus evidence presented with glucose below 200 mg/dL (11.1 mmol/L). This is euglycemic DKA: the ketone and acidosis criteria are present even though glucose does not look conventionally high.1

Euglycemic DKA can occur after insulin has already been taken, during reduced food intake, in pregnancy, with alcohol-related impaired gluconeogenesis, with liver failure, and during treatment with a sodium-glucose cotransporter-2 (SGLT2) inhibitor. Examples of SGLT2 inhibitors include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin.

The FDA warns that people taking an SGLT2 inhibitor should be assessed for ketoacidosis when compatible symptoms occur regardless of glucose level. Reported precipitating factors include insulin-dose reduction, acute illness, surgery, reduced caloric intake, pancreatic insulin deficiency, and alcohol use. The FDA directs patients with suspected symptoms to stop the SGLT2 inhibitor and seek medical attention immediately.2

Do not combine an SGLT2 inhibitor with a ketogenic or very-low-carbohydrate diet without a medication-specific plan from the prescriber. Do not reduce or omit insulin to avoid low glucose after changing carbohydrate intake.

Pregnancy, illness, and other high-risk settings

Pregnancy can increase susceptibility to ketosis and DKA, and DKA may occur at lower glucose concentrations. Vomiting, reduced intake, infection, or insulin-delivery problems during pregnancy require prompt contact with the obstetric and diabetes teams; DKA symptoms require emergency assessment.1

People with type 1 diabetes, a history of DKA, pancreatic disease or surgery, an insulin pump, or insulin-treated type 2 diabetes need an individualized sick-day and ketone-testing plan. Pump interruption can remove rapid-acting insulin quickly. Insulin should not be stopped during illness unless the diabetes team gives explicit instructions.

Ketoacidosis can also occur outside diabetes in distinct syndromes linked to prolonged starvation or heavy alcohol use. These conditions have different causes from DKA but can still produce dangerous metabolic acidosis and require urgent clinical care.

Symptoms and what to do

DKA symptoms may include excessive thirst, frequent urination, nausea, vomiting, abdominal pain, profound fatigue, deep or rapid breathing, shortness of breath, confusion, or reduced alertness. Breath odor is neither sensitive nor specific enough to distinguish DKA from dietary ketosis.1 3

  • Call emergency services or go to an emergency department now for trouble breathing, deep rapid breathing, confusion, fainting, severe drowsiness, or persistent vomiting, especially with diabetes, pregnancy, or SGLT2-inhibitor use.
  • Follow the established diabetes sick-day plan for glucose and ketone checks. Seek urgent clinical advice at the threshold specified by the diabetes team; do not wait for high glucose if symptoms or ketones are concerning.
  • Do not try to treat suspected DKA with water, food, exercise, or extra supplements. DKA treatment requires clinical assessment, fluids, insulin, electrolyte management, and treatment of the precipitating cause.1

If an unexpected home result appears in someone without diabetes or symptoms, repeat it only as the device instructions advise and discuss persistent or unexplained readings with a clinician. Routine testing to maximize ketones offers no established health benefit.

Frequently Asked Questions

Can one ketone reading diagnose DKA?
No. DKA requires diabetes or qualifying hyperglycemia, elevated ketones, and metabolic acidosis. A home meter can measure ketones but cannot measure the pH or bicarbonate needed to assess acidosis.
Can DKA happen with normal blood sugar?
Yes. Euglycemic DKA meets the ketone and acidosis criteria while glucose is below 200 mg/dL. It is associated with SGLT2 inhibitors, pregnancy, reduced food intake, alcohol-related impaired gluconeogenesis, liver failure, and insulin already taken before testing.
Does fruity breath prove DKA?
No. Breath odor can occur with dietary ketosis and is not a reliable way to diagnose or exclude DKA. Symptoms, medical context, blood BHB, and acid-base testing matter.
Who should have a home ketone-testing plan?
People at risk of DKA, especially those with type 1 diabetes or a previous episode, should follow the individualized sick-day and ketone-testing plan supplied by their diabetes team.
Should I track ketones on a keto diet?
Routine ketone testing is generally unnecessary for a ketogenic diet used outside a prescribed therapeutic program. A higher number is not automatically safer or more beneficial.

Works cited

  1. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report — Umpierrez GE, Davis GM, ElSayed NA, et al., Diabetes Care. 2024;47(8):1257–1275, doi:10.2337/dci24-0032August 23, 2026 https://pmc.ncbi.nlm.nih.gov/articles/PMC11272983/
  2. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections — U.S. Food and Drug Administration, revised March 15, 2022August 23, 2026 https://www.fda.gov/files/drugs/published/FDA-revises-labels-of-SGLT2-inhibitors-for-diabetes-to-include-warnings-about-too-much-acid-in-the-blood-and-serious-urinary-tract-infections.pdf
  3. Managing Diabetes — National Institute of Diabetes and Digestive and Kidney DiseasesAugust 23, 2026 https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes
  4. Multi-Dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics — Puchalska P, Crawford PA, Cell Metabolism. 2017;25(2):262–284, doi:10.1016/j.cmet.2016.12.022 https://pmc.ncbi.nlm.nih.gov/articles/PMC5313038/

Article history

  1. Updated
  2. First published

Your learning guide

Loading reading status…